AMAL director sells 6,697 shares, receives 2,311 RSUs on Form 4
Amalgamated Financial Corp. (AMAL) reported insider activity by a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amalgamated Financial Corp. (AMAL) reported insider activity by a director. On 10/30/2025, the director exercised non-qualified stock options for 4,820 shares at $12, 4,220 shares at $13.75, and 3,960 shares at $14.65. Shares were withheld for taxes the same day: 2,340, 2,048, and 1,922 at $27.5575.
On 10/31/2025, the director sold 6,697 shares at a weighted average price of $27.3416, with trades ranging from $27.06 to $27.635. On 11/01/2025, the director received a grant of 2,311 restricted stock units that vested immediately. Following these transactions, the director beneficially owned 19,074 shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,311 | $0.00 | $0.00 |
| Sale | Common Stock | 6,697 | $27.3416 | $183K |
| Exercise | Non-Qualified Stock Option (right to buy) | 4,820 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 4,220 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 3,960 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,820 | $12.00 | $58K |
| Exercise Price or Tax Liability | Common Stock | 2,340 | $27.5575 | $64K |
| Exercise | Common Stock | 4,220 | $13.75 | $58K |
| Exercise Price or Tax Liability | Common Stock | 2,048 | $27.5575 | $56K |
| Exercise | Common Stock | 3,960 | $14.65 | $58K |
| Exercise Price or Tax Liability | Common Stock | 1,922 | $27.5575 | $53K |
Footnotes (2)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.635 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- F2. The reported transaction involved the reporting person's receipt of a grant of 2,311 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions were reported for AMAL?
What option exercises did the AMAL director complete?
What equity award did the AMAL director receive?
AI-generated analysis. How Rhea-AI works. Not financial advice.